Illum L - Search Results

1

Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance.

Stolnik S, Heald CR, Neal J, Garnett MC, Davis SS, Illum L, Purkis SC, Barlow RJ, Gellert PR. Stolnik S, et al. Among authors: illum l. J Drug Target. 2001;9(5):361-78. doi: 10.3109/10611860108998772. J Drug Target. 2001. PMID: 11770706

2

Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.

Charlton ST, Davis SS, Illum L. Charlton ST, et al. Among authors: illum l. J Drug Target. 2007 Jun;15(5):370-7. doi: 10.1080/10611860701393370. J Drug Target. 2007. PMID: 17541846

3

Microspheres as drug carriers.

Davis SS, Illum L. Davis SS, et al. Among authors: illum l. Horiz Biochem Biophys. 1989;9:131-53. Horiz Biochem Biophys. 1989. PMID: 2656474 Review. No abstract available.

4

Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.

Dunn SE, Brindley A, Davis SS, Davies MC, Illum L. Dunn SE, et al. Among authors: illum l. Pharm Res. 1994 Jul;11(7):1016-22. doi: 10.1023/a:1018939521589. Pharm Res. 1994. PMID: 7937542

5

Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method.

Lin W, Coombes AG, Davies MC, Davis SS, Illum L. Lin W, et al. Among authors: illum l. J Drug Target. 1993;1(3):237-43. doi: 10.3109/10611869308996081. J Drug Target. 1993. PMID: 8069565

6

Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.

Neal JC, Stolnik S, Garnett MC, Davis SS, Illum L. Neal JC, et al. Among authors: illum l. Pharm Res. 1998 Feb;15(2):318-24. doi: 10.1023/a:1011987206722. Pharm Res. 1998. PMID: 9523321

7

The effect of lymphatic oedema on the uptake of colloids to the lymph nodes.

Hawley AE, Illum L, Davis SS. Hawley AE, et al. Among authors: illum l. Biopharm Drug Dispos. 1998 Apr;19(3):193-7. doi: 10.1002/(sici)1099-081x(199804)19:3<193::aid-bdd88>3.0.co;2-v. Biopharm Drug Dispos. 1998. PMID: 9570003

8

Defining the drug incorporation properties of PLA-PEG nanoparticles.

Govender T, Riley T, Ehtezazi T, Garnett MC, Stolnik S, Illum L, Davis SS. Govender T, et al. Among authors: illum l. Int J Pharm. 2000 Apr 10;199(1):95-110. doi: 10.1016/s0378-5173(00)00375-6. Int J Pharm. 2000. PMID: 10794931

9

Schizophrenia and drug delivery systems.

Cheng YH, Illum L, Davis SS. Cheng YH, et al. Among authors: illum l. J Drug Target. 2000;8(2):107-17. doi: 10.3109/10611860008996856. J Drug Target. 2000. PMID: 10852342 Review.

10

The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers.

Stolnik S, Daudali B, Arien A, Whetstone J, Heald CR, Garnett MC, Davis SS, Illum L. Stolnik S, et al. Among authors: illum l. Biochim Biophys Acta. 2001 Oct 1;1514(2):261-79. doi: 10.1016/s0005-2736(01)00376-5. Biochim Biophys Acta. 2001. PMID: 11557026 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters